Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Details Narrative)

v3.21.1
WARRANTS (Details Narrative) - USD ($)
 3 Months Ended
Oct. 16, 2020
Jul. 28, 2020
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Jun. 28, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Fair value of warrants issued     $ 6,215,225      
Debt face amount     $ 20,000,000   $ 20,000,000  
Share-based Payment Arrangement, Tranche One [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Debt face amount   $ 20,000,000        
Loan Agreement [Member] | K2 HealthVentures LLC [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants to purchase shares of common stock, exercised   86,206        
Exercise price of warrants   $ 6.96        
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Debt face amount           $ 50,000,000
Warrant [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants to purchase shares of common stock, exercised     0 0    
Warrant [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants to purchase shares of common stock, exercised   86,206        
Exercise price of warrants   $ 6.96        
Fair value of warrants issued   $ 472,409        
Warrant expire date   Jul. 28, 2030        
Warrant [Member] | Professional Services Agreement [Member] | Investor Relations Service Provider [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants outstanding to purchase of common stock shares 420,000          
Exercise price of warrants $ 1.07          
Fair value of warrants issued $ 334,740          
CFF Warrant [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants outstanding to purchase of common stock shares     1,000,000      
Exercise price of warrants     $ 13.20      
CFF Warrant [Member] | Investment Agreement [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants outstanding to purchase of common stock shares     1,506,206      
Exercise price of warrants     $ 9.46      
Weighted average remaining life of warrants     4 years 4 months 9 days      
Number of warrants exercisable for common stock     500,000      
Warrant expire date         Jan. 26, 2025